Soleno Therapeutics | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(5.2%)
Soleno Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-The Carlyle Group Inc.(4.99%),Carlyle Holdings I GP Inc.(4.99%)等
Soleno Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-The Carlyle Group Inc.(6.2%),Carlyle Holdings I GP Inc.(6.2%)等
Soleno Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-The Carlyle Group Inc.(8.1%),Carlyle Holdings I GP Inc.(8.1%)等
Soleno Therapeutics | 4:持股变动声明-高管 Yen Kristen
Soleno Therapeutics | 4:持股变动声明-高管 Mackaness James H
Soleno Therapeutics | 4:持股变动声明-高管 Hirano Patricia C
Soleno Therapeutics | 4:持股变动声明-高管 Anish Bhatnagar
Soleno Therapeutics | SC 13G:超过5%持股股东披露文件-Janus Henderson Group plc(10.1%)
Soleno Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-The Carlyle Group Inc.(9.99%),Carlyle Holdings I GP Inc.(9.99%)等
Soleno Therapeutics | SC 13G:超过5%持股股东披露文件-Vivo Opportunity Fund Holdings, L.P.(16.2%),Vivo Opportunity, LLC(16.2%)
Soleno Therapeutics | 4:持股变动声明-高管 Yen Kristen
Soleno Therapeutics | 4:持股变动声明-高管 Mackaness James H
Soleno Therapeutics | 4:持股变动声明-高管 Hirano Patricia C
Soleno Therapeutics | 4:持股变动声明-高管 Anish Bhatnagar
Soleno Therapeutics | 4:持股变动声明-股东 Vivo Opportunity, LLC
Soleno Therapeutics | 4:持股变动声明-高管 Urbanski Raymond W.
Soleno Therapeutics | 3:首次持股声明-高管 Urbanski Raymond W.
Soleno Therapeutics | 4:持股变动声明-董事 Bir Dawn Carter
Soleno Therapeutics | 3:首次持股声明-董事 Bir Dawn Carter
暂无数据
暂无数据